SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-040828
Filing Date
2021-08-09
Accepted
2021-08-06 18:36:02
Documents
43
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_bctgacquisition.htm   iXBRL 10-Q 434240
2 CERTIFICATION f10q0621ex31-1_bctgacq.htm EX-31.1 11566
3 CERTIFICATION f10q0621ex31-2_bctgacq.htm EX-31.2 10700
4 CERTIFICATION f10q0621ex32-1_bctgacq.htm EX-32.1 4159
5 CERTIFICATION f10q0621ex32-2_bctgacq.htm EX-32.2 4124
  Complete submission text file 0001213900-21-040828.txt   2597873

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bctg-20210630.xsd EX-101.SCH 30609
7 XBRL CALCULATION FILE bctg-20210630_cal.xml EX-101.CAL 18403
8 XBRL DEFINITION FILE bctg-20210630_def.xml EX-101.DEF 135751
9 XBRL LABEL FILE bctg-20210630_lab.xml EX-101.LAB 255098
10 XBRL PRESENTATION FILE bctg-20210630_pre.xml EX-101.PRE 141673
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_bctgacquisition_htm.xml XML 256860
Mailing Address 12860 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130
Business Address 12860 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 (858) 400-3115
BCTG Acquisition Corp. (Filer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39485 | Film No.: 211154150
SIC: 2834 Pharmaceutical Preparations